FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068993397> ?p ?o ?g. }

• W2068993397 endingPage "663" @default.
• W2068993397 startingPage "657" @default.
• W2068993397 abstract "We investigated whether chronic rosuvastatin administration could improve the abnormalities of the circulating levels of vascular dysfunction markers in pulmonary arterial hypertension (PAH). Sixty patients, aged 13 to 60 years, with idiopathic (N = 14) or congenital heart disease-associated PAH (N = 46) were equally but randomly assigned to rosuvastatin treatment (10 mg a day, orally) or placebo for 6 months in a blind fashion. Plasma levels of P-selectin, tissue-plasminogen activator and its inhibitor as well as von Willebrand factor antigen were measured by enzyme-linked immunoassay before and after 1, 3, and 6 months of treatment. Baseline levels of biomarkers were elevated (68, 16, 45 and 46% increase relative to controls, for P-selectin, von Willebrand factor antigen, tissue-plasminogen activator and its inhibitor, respectively; P < 0.001). P-selectin values at baseline, 1, 3, and 6 months were 39.9 ± 18.5, 37.6 ± 14.6, 34.8 ± 14.6, and 35.4 ± 13.9 ng/mL, respectively, for the rosuvastatin group and 45.7 ± 26.8, 48.0 ± 26.9, 48.1 ± 25.7, and 45.7 ± 25.6 ng/mL for the placebo group. The P-selectin level was lower in the rosuvastatin group compared with placebo throughout treatment (P = 0.037, general linear model). A trend was observed towards a decrease in tissue-plasminogen activator in the statin group (16% reduction, P = 0.094), with no significant changes in the other markers. Since P-selectin is crucial in inflammation and thrombosis, its reduction by rosuvastatin is potentially relevant in the pathophysiological scenario of PAH." @default.
• W2068993397 created "2016-06-24" @default.
• W2068993397 creator A5020946758 @default.
• W2068993397 creator A5025207825 @default.
• W2068993397 creator A5060215294 @default.
• W2068993397 creator A5072668822 @default.
• W2068993397 creator A5083587568 @default.
• W2068993397 date "2008-08-01" @default.
• W2068993397 modified "2023-09-28" @default.
• W2068993397 title "Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled study" @default.
• W2068993397 cites W1840736932 @default.
• W2068993397 cites W1968388902 @default.
• W2068993397 cites W1973936601 @default.
• W2068993397 cites W1994607275 @default.
• W2068993397 cites W2021239133 @default.
• W2068993397 cites W2026338569 @default.
• W2068993397 cites W2037143634 @default.
• W2068993397 cites W2042928998 @default.
• W2068993397 cites W2048443661 @default.
• W2068993397 cites W2051255785 @default.
• W2068993397 cites W2052164212 @default.
• W2068993397 cites W2065194987 @default.
• W2068993397 cites W2070666561 @default.
• W2068993397 cites W2079335526 @default.
• W2068993397 cites W2081013641 @default.
• W2068993397 cites W2090213540 @default.
• W2068993397 cites W2097764902 @default.
• W2068993397 cites W2098586577 @default.
• W2068993397 cites W2099426430 @default.
• W2068993397 cites W2105570450 @default.
• W2068993397 cites W2111274165 @default.
• W2068993397 cites W2113554645 @default.
• W2068993397 cites W2119718845 @default.
• W2068993397 cites W2121376498 @default.
• W2068993397 cites W2158323763 @default.
• W2068993397 cites W2158657788 @default.
• W2068993397 cites W2161934309 @default.
• W2068993397 cites W2321522617 @default.
• W2068993397 cites W2468172675 @default.
• W2068993397 doi "https://doi.org/10.1590/s0100-879x2008000800003" @default.
• W2068993397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18797697" @default.
• W2068993397 hasPublicationYear "2008" @default.
• W2068993397 type Work @default.
• W2068993397 sameAs 2068993397 @default.
• W2068993397 citedByCount "30" @default.
• W2068993397 countsByYear W20689933972012 @default.
• W2068993397 countsByYear W20689933972013 @default.
• W2068993397 countsByYear W20689933972014 @default.
• W2068993397 countsByYear W20689933972016 @default.
• W2068993397 countsByYear W20689933972017 @default.
• W2068993397 countsByYear W20689933972018 @default.
• W2068993397 countsByYear W20689933972019 @default.
• W2068993397 countsByYear W20689933972021 @default.
• W2068993397 crossrefType "journal-article" @default.
• W2068993397 hasAuthorship W2068993397A5020946758 @default.
• W2068993397 hasAuthorship W2068993397A5025207825 @default.
• W2068993397 hasAuthorship W2068993397A5060215294 @default.
• W2068993397 hasAuthorship W2068993397A5072668822 @default.
• W2068993397 hasAuthorship W2068993397A5083587568 @default.
• W2068993397 hasBestOaLocation W20689933973 @default.
• W2068993397 hasConcept C126322002 @default.
• W2068993397 hasConcept C134018914 @default.
• W2068993397 hasConcept C142724271 @default.
• W2068993397 hasConcept C204787440 @default.
• W2068993397 hasConcept C27081682 @default.
• W2068993397 hasConcept C2776839432 @default.
• W2068993397 hasConcept C2779394231 @default.
• W2068993397 hasConcept C2779679481 @default.
• W2068993397 hasConcept C2780499067 @default.
• W2068993397 hasConcept C2908737378 @default.
• W2068993397 hasConcept C71924100 @default.
• W2068993397 hasConcept C89560881 @default.
• W2068993397 hasConcept C90924648 @default.
• W2068993397 hasConceptScore W2068993397C126322002 @default.
• W2068993397 hasConceptScore W2068993397C134018914 @default.
• W2068993397 hasConceptScore W2068993397C142724271 @default.
• W2068993397 hasConceptScore W2068993397C204787440 @default.
• W2068993397 hasConceptScore W2068993397C27081682 @default.
• W2068993397 hasConceptScore W2068993397C2776839432 @default.
• W2068993397 hasConceptScore W2068993397C2779394231 @default.
• W2068993397 hasConceptScore W2068993397C2779679481 @default.
• W2068993397 hasConceptScore W2068993397C2780499067 @default.
• W2068993397 hasConceptScore W2068993397C2908737378 @default.
• W2068993397 hasConceptScore W2068993397C71924100 @default.
• W2068993397 hasConceptScore W2068993397C89560881 @default.
• W2068993397 hasConceptScore W2068993397C90924648 @default.
• W2068993397 hasIssue "8" @default.
• W2068993397 hasLocation W20689933971 @default.
• W2068993397 hasLocation W20689933972 @default.
• W2068993397 hasLocation W20689933973 @default.
• W2068993397 hasLocation W20689933974 @default.
• W2068993397 hasLocation W20689933975 @default.
• W2068993397 hasOpenAccess W2068993397 @default.
• W2068993397 hasPrimaryLocation W20689933971 @default.
• W2068993397 hasRelatedWork W1547731601 @default.
• W2068993397 hasRelatedWork W1594507530 @default.
• W2068993397 hasRelatedWork W1781372697 @default.
• W2068993397 hasRelatedWork W2054150405 @default.

• next